Reply to the letter regarding the article ‘Efficacy and safety of tafamidis doses in the Tafamidis in Transthyretin Cardiomyopathy Clinical Trial (ATTR‐ACT) and long‐term extension study’

Detalles Bibliográficos
Autores principales: Damy, Thibaud, Sultan, Marla B., Witteles, Ronald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359258/
https://www.ncbi.nlm.nih.gov/pubmed/33340199
http://dx.doi.org/10.1002/ejhf.2074

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8359258/
https://www.ncbi.nlm.nih.gov/pubmed/33340199
http://dx.doi.org/10.1002/ejhf.2074

Ejemplares similares